Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

310
Milken Institute Statement on the Bipartisan EDA Reauthorization article
Milken Institute Statement on the Bipartisan EDA Reauthorization
Milken Institute Senior Director Dan Carol made the following statement regarding the proposed reaut
horization of the Public Works and Economic Development Act of 1965:
Mar 11, 2024
Biswas Family Foundation Transformative Computational Biology Grant Awardees article
Biswas Family Foundation Transformative Computational Biology Grant Awardees
The Biswas Family Foundation and the Milken Institute are pleased to announce the five research team
s selected to receive funding in the first cycle of the Tran
Mar 12, 2024
Milken Institute Statement on the Bipartisan, Bicameral Americas Act article
Milken Institute Statement on the Bipartisan, Bicameral Americas Act
“The Americas Act will strengthen US economic competitiveness, bolster critical supply chain resilie
nce, and deepen important partnerships in the Western Hemisphere through the expansion of trade and investment,” said Mike Piwowar, Executive Vice Presid
Mar 6, 2024
Inclusive Capitalism Program Insights: March 2024 article
Inclusive Capitalism Program Insights: March 2024
For 2024, the Inclusive Capitalism (ICAP) team continues to commit to the crucial change work needed
to lead the industry in a more inclusive direction.
Mar 7, 2024
The Milken Institute 2024 Global Opportunity Index Rankings Reflect Optimism Among Investors, While Financial Conditions Remain Tight Amid Warnings of Interest Rate Hikes and a Global Slowdown article
The Milken Institute 2024 Global Opportunity Index Rankings Reflect Optimism Among Investors, While Financial Conditions Remain Tight Amid Warnings of Interest Rate Hikes and a Global Slowdown
WASHINGTON, DC (March 5, 2024) — Optimism and opportunity, balanced against a world in flu
x, are influencing global investment decisions, according to a new report by the nonpartisan Milken Institute.
Mar 5, 2024
Food and Drug Administration (FDA) - Patient Perspectives on Gene Therapy Products article
Food and Drug Administration (FDA) - Patient Perspectives on Gene Therapy Products
Submitted electronically Division of Dockets Management (HFA-305) Food and Drug Administration Dock
et No: FDA-2022-N-2394 5630 Fishers Lane Room 1061 Rockville, MD 20852
Dec 15, 2022
OSTP RFI on Clinical Research Infrastructure and Emergency Clinical Trials article
OSTP RFI on Clinical Research Infrastructure and Emergency Clinical Trials
Submitted electronically Dr. Arati Prabhakar Director Office of Science and Technology Policy The W
hite House Washington, DC 20502
Dec 27, 2022
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package article
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package
The Milken Institute applauds Congress on the passage of the FY2023 Omnibus Appropriations bill.
Dec 23, 2022
FinTech in Focus — December 27, 2022 article
FinTech in Focus — December 27, 2022
In This Newsletter US Africa Summit Household Crypto Usage Takeaways from FTX’s Collapse
Dec 27, 2022
Center for Strategic Philanthropy: 2022 Year-End Newsletter article
Center for Strategic Philanthropy: 2022 Year-End Newsletter
In This Issue Program Updates Reports and Resources CSP and Our Partners in the News Highlights fro
m Milken Institute Convenings
Dec 20, 2022
End-of-Year Legislative Package – Retirement Security Provisions comment letter article
End-of-Year Legislative Package – Retirement Security Provisions comment letter
Submitted electronically  The Honorable Chuck Schumer Majority Leader Unite
d States Senate Washington, DC 20510
Dec 12, 2022
FinTech in Focus — December 13, 2022 article
FinTech in Focus — December 13, 2022
In This Newsletter Unlocking the Power of Blockchain: Real World Use Cases The Next FinTech Unicorn
: Investment Opportunities in FinTech
Dec 13, 2022